期刊
CURRENT OPINION IN BIOMEDICAL ENGINEERING
卷 28, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.cobme.2023.100491
关键词
CRISPR/Cas9; Genome editing; Large fragment knock-in; Transposase; Recombinase; Genomic insertion
CRISPR/Cas-based gene-editing technologies have revolutionized genome science and provided unprecedented possibilities for research. Recent developments have focused on long-sequence gene editing, particularly the insertion of large fragments into the genome. Despite challenges, this field continues to rapidly evolve and holds the potential for revolutionary biomedical applications.
CRISPR/Cas-based gene-editing technologies have emerged as one of the most transformative tools in genome science over the past decade, providing unprecedented possibilities for both fundamental and translational research. Following the initial wave of innovations for gene knock-out, epigenetic/RNA modulation, and nickase-mediated base-editing, recent efforts have pivoted towards long-sequence gene editing- specifically, the insertion of large fragments (>1 kb) into the endogenous genome. In this review, we survey the development of these CRISPR/Cas-based sequence insertion methodologies in conjunction with the emergence of novel families of editing enzymes, such as transposases, single-stranded DNA-annealing proteins, recombinases, and integrases. Despite facing a number of challenges, this field continues to evolve rapidly and holds the potential to catalyze a new wave of revolutionary biomedical applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据